LBO — SUTTER ROSEVILLE MEDICAL CENTER
IRR: 16.4% | MOIC: 2.14x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
16.4%
IRR
2.14x
MOIC
$1.3B
Entry EV
$2.0B
Exit EV
$685.7M
Equity Invested
Sources & Uses
S&UTotal · $1.3B| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $517.5M | 38.8% | |
| Sub Debt | $129.4M | 9.7% | |
| Equity | $685.7M | 51.5% | |
| Enterprise Value | $1.3B | 97.1% | |
| Transaction Fees | $38.8M | 2.9% | |
| Total Uses | $1.3B | 100.0% |
Interpretation
INTAt 2.14x MOIC and 16.4% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $189.9M |
| Exit Ev | $2.0B |
| Net Debt At Exit | $527.0M |
| Equity At Exit | $1.5B |
| Equity Invested | $685.7M |
| Total Value Created | $781.8M |
| Value From Growth | $636.0M |
| Value From Multiple | $64.7M |
| Value From Deleveraging | $119.9M |